Residual limb neuropathic pain association with neuroma, prosthetic, function, and participation outcomes in individuals living with a transtibial amputation: an exploratory study
Journal of Rehabilitation Medicine · 2025
DOI: 10.2340/jrm.v57.40551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Rehabilitation Medicine, 2025. Verfasst von Camille Fournier-Farley und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Interdisciplinary Rehabilitation Research of Greater Montreal (CRIR) - Centre Intégré Universitaire de Santé et de Services Sociaux du Cen…. Hauptthemen laut MEDLINE: Neuroma, Neuralgia, Artificial Limbs, Amputation, Surgical. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To determine the strength of the association between residual limb neuropathic pain intensity and the number of neuromas, prosthetic, functional, and participation outcomes, and assess whether ultrasound (US) biomarkers of neuromas differ between pain intensities.
Design
Cross-sectional study. Subjects: Twenty-two participants with a transtibial amputation for more than 12 months, with and without residual limb neuropathic pain.
Methods
Participants completed questionnaires (Numerical Pain Rating Scale, Pain Disability Index (PDI), Prosthetic Profile of the Amputee-Locomotor Capabilities Index), and had their residual limbs examined by US. Whenever a neuroma was diagnosed during US, images of the neuroma(s) were recorded and US biomarkers were computed.
Results
Of the 27 neuromas diagnosed, pain intensity was associated with no use of walking aid, less daily prosthesis wearing time, a higher PDI score, and a neuroma at the common fibular nerve. The cross-sectional area, the thickness ratio, or the thickness of the overlying tissues was not associated with pain intensity.
Conclusion
Though the results enrich currently available evidence on clinical variables potentially associated with the intensity of neuropathic pain in individuals living with a transtibial amputation, and on the limited value of US biomarkers studied to determine the association between neuroma(s) and pain intensity, future studies providing higher quality evidence remain needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Interdisciplinary Rehabilitation Research of Greater Montreal (CRIR) - Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal, Montréal, Québec, Canada; Faculty of Med…
- Faculty of Medicine, Physical Medicine and Rehabilitation Program, Université de Montréal, Montréal, Québec, Canada; Physical Medicine and Rehabilitation Service, Department of Medicine, Centre hospitalier de l'Universi…
- Centre for Interdisciplinary Rehabilitation Research of Greater Montreal (CRIR) - Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal, Montréal, Québec, Canada; School of Reha…
Zitieren
APA
Fournier-Farley, C., Boudier-Revéret, M., & Gagnon, D. H. (2025). Residual limb neuropathic pain association with neuroma, prosthetic, function, and participation outcomes in individuals living with a transtibial amputation: an exploratory study. Journal of Rehabilitation Medicine. https://doi.org/10.2340/jrm.v57.40551
Vancouver
Fournier-Farley C, Boudier-Revéret M, Gagnon DH. Residual limb neuropathic pain association with neuroma, prosthetic, function, and participation outcomes in individuals living with a transtibial amputation: an exploratory study. Journal of Rehabilitation Medicine. 2025. doi:10.2340/jrm.v57.40551
BibTeX
@article{FournierFarley2025,
author = {Fournier-Farley, Camille and Boudier-Revéret, Mathieu and Gagnon, Dany H},
title = {Residual limb neuropathic pain association with neuroma, prosthetic, function, and participation outcomes in individuals living with a transtibial amputation: an exploratory study},
journal = {Journal of Rehabilitation Medicine},
year = {2025},
doi = {10.2340/jrm.v57.40551}
}
EUVIMED